Who invested in Orionis Biosciences

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$59Mraised across 2 rounds since 2015, from 2 sources

$4.0MVenture$55MSeries C

Latest round: Series C, $55MOct 2022
Step-upi: 13.7×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2016201720182019202020212022

$4.0MVenture$55MSeries C

First round: Venture, $4.0M
Biggest round: $55M
Between rounds: 7 years

The rounds

Oct 2022
Series C$55M2 new
- Cormorant Asset Management
- Novartis
Source recorded
Oct 2015
Venture$4.0M
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale Sept 2015

Founders and team

From the SEC filings it signed: 3 on the team.

Griet R. VanpouckeManageri
Nikolai KleyManageri
Steven R. GullansManageri

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2015Series C2022

Cormorant Asset Management

Novartis

Everyone who backed them

Cormorant Asset ManagementPrivate equity1round

NovartisVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Orionis Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.